Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Clinical Nephrology
You have accessRestricted Access

Urinary Albumin Excretion Is Associated with Renal Functional Abnormalities in a Nondiabetic Population

SARA-JOAN PINTO-SIETSMA, WILBERT M.T. JANSSEN, HANS L. HILLEGE, GERJAN NAVIS, DICK DE ZEEUW and PAUL E. DE JONG
JASN October 2000, 11 (10) 1882-1888;
SARA-JOAN PINTO-SIETSMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WILBERT M.T. JANSSEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANS L. HILLEGE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GERJAN NAVIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DICK DE ZEEUW
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAUL E. DE JONG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

Abstract. Microalbuminuria (MA) is an important early sign of diabetic nephropathy. Hyperfiltration and impaired filtration in relation to albuminuria has been well investigated in diabetic subjects. This study tested the hypothesis that an increased urinary albumin excretion (UAE) is associated with renal functional abnormalities also in nondiabetic subjects. The relation between UAE and creatinine clearances (Ccr) in 7728 nondiabetic subjects was studied. Subjects were divided in four groups according to UAE (mg/24 h): 0 to 15 (control), 15 to 30 (high-normal albuminuria [HNA]), 30 to 300 (MA), >300 (macroalbuminuria). An elevated filtration and a diminished filtration were defined as a Ccr exceeding or below 2× the SD of the control group corrected for age and gender. Ccr followed a parabolic trend, with a higher Ccr in the HNA as compared with control and a lower Ccr in the MA and macroalbuminuria group as compared with HNA. With each increasing UAE level, male sex, age, body mass index, minimal waist circumference, systolic and diastolic BP, plasma glucose, and a positive family history for diabetes all followed a significant linear increasing trend (P < 0.001). After adjustment for age, gender, body mass index, plasma glucose, a positive family history for diabetes, systolic and diastolic BP, antihypertensive medication, and smoking in a multivariate analysis, HNA and MA were independently associated with an elevated filtration (RR 1.8 [95% confidence interval, 1.30 to 2.51] and 1.7 [1.17 to 2.45]). Macroalbuminuria was independently associated with a diminished filtration (4.3 [range, 1.97 to 9.36]). In conclusion, an elevated UAE might be an important and early sign for progressive renal function loss in a nondiabetic population.

Microalbuminuria (MA; 30 to 300 mg/24 h) is an important early sign of incipient diabetic nephropathy in insulin-dependent diabetes mellitus (IDDM) (1,2) and, albeit less specific, in non—insulin-dependent diabetes mellitus (NIDDM) (3,4). Hyperfiltration has been observed in both IDDM (5,6,7,8) and NIDDM (9,10) and is thought to occur before the renal function loss (11). Therefore, in diabetic patients, the development of nephropathy typically follows a biphasic pattern, characterized by MA and hyperfiltration in the initial phase, followed by progression to overt proteinuria and renal function decline once overt nephropathy ensues.

Whether this biphasic pattern is typical for diabetic nephropathy or can also be observed in nondiabetic renal disease is still unknown. From animal experimental data, it has been suggested that a period of hyperfiltration might precede progressive renal function loss in nondiabetic renal disease (12,13). Furthermore, from other animal experiments, there is evidence that hyperfiltration induces proteinuria (14), suggesting that the concomitant increased intraglomerular pressure in hyperfiltration might be responsible for both albuminuria/proteinuria and the later renal function loss (15,16).

It is interesting that MA also occurs frequently in nondiabetic subjects and is associated with several risk factors, such as hypertension (17), hyperlipidemia (18,19), obesity (20), and older age (21). Little is known about the relation between albuminuria and renal function in nondiabetic subjects, especially whether nondiabetic subjects also exert early renal functional changes such as hyperfiltration, because they usually come to medical attention only after the development of renal damage. We therefore hypothesized that an increased urinary albumin excretion (UAE) is associated with early and late renal functional abnormalities, such as an elevated filtration and a diminished filtration in a nondiabetic population. To test this hypothesis, we studied renal function in relation to UAE in a large cross-sectional study of nondiabetic subjects in the city of Groningen, the Netherlands.

Materials and Methods

Study Population

This study is part of the ongoing PREVEND study (Prevention of REnal and Vascular ENd stage Disease), running in the city of Groningen, the Netherlands. All inhabitants of the city of Groningen between the ages of 28 and 75 yr (85,421 subjects) were asked to send in a morning urine sample and to fill out a short questionnaire on demographics and cardiovascular history. A total of 40,856 subjects (47.8%) responded. From this group, 30,890 subjects had a urinary albumin concentration of <10 mg/L and 9966 subjects had a urinary albumin concentration of ≥10 mg/L in their morning urine sample. After exclusion of subjects with IDDM and pregnant women, all subjects with a urinary albumin concentration of ≥10 mg/L (n = 7768) together with a randomly selected control group with a urinary albumin concentration of <10 mg/L (n = 3395) were invited for further investigations in an outpatient clinic (total n = 11,163). Finally, 8592 subjects completed the total screening program, rendering us the actual study cohort. The study was approved by the medical ethics committee and conducted in accordance with the guidelines of the declaration of Helsinki. All participants who attended the outpatient clinic gave written informed consent.

Study Design

The screening program in the outpatient clinic consisted of two visits. At the first visit, participants completed a self-administered questionnaire regarding demographics; cardiovascular and renal history; family history on diabetes; and the use of medication for diabetes, hypertension, or hyperlipidemia. Subjects were classified as having renal disease when they were being treated for proteinuria as a consequence of renal disease, and subjects were classified as having a positive family history for diabetes when at least one first-degree relative had diabetes. After shoes and heavy clothing were removed, weight was measured to the nearest 0.5 kg with a Seca balance scale (Vogel and Halke, Hamburg, Germany). Height was measured to the nearest 0.5 cm. Minimal waist circumference was measured on bare skin at the natural indentation between the 10th rib and the iliac crest (22). At both visits, BP was measured in supine position, every minute, for 10 and 8 min, respectively, with an automatic Dinamap XL Model 9300 series device (Johnson and Johnson, Medical Inc., Arlington, TX). Subjects were asked to collect two consecutive 24-h urine in the last week before the second visit. The subjects were given oral and written instructions on how to collect 24-h urine, and they were instructed to postpone urine collection in case of fever, urinary tract infection, or menstruation and to refrain from heavy exercise during collection as much as possible. Furthermore, the subjects were asked to store the urine cold (4°C) for a maximum of 4 d before the second visit. Measurements of urinary volume and albumin and creatinine concentrations were performed for each collection. At the second visit, blood was drawn, after an overnight fast, for determination of plasma glucose and serum creatinine.

Calculations

Systolic and diastolic BP was calculated as the mean of the last two measurements of the two visits. Body mass index (BMI) was calculated as the ratio between weight (kg) and the square of height (m) (weight/height2). Body surface area (BSA) was calculated according to DuBois and DuBois (23). UAE was calculated as the mean of the two 24-h UAE. Similar to most large epidemiologic studies, we estimated GFR according to the Cockcroft and Gault formula (24), but because we also collected 24-h urine, we were also able to calculate creatinine clearance (Ccr) by taking the mean of the two 24-h urinary creatinine excretions divided by plasma creatinine and corrected for BSA (ml/min-1 per 1.73m-2). We analyzed our data both with the Cockcroft clearance and the Ccr. Because both analyses gave the same results, we show the results only of the Ccr. Because 24-h urine collection might be inaccurate as a result of collection errors, we carried out a second validation step. First, we analyzed our data after excluding subjects who had a difference between their 24-h Ccr and Cockcroft clearance of 2× the SD according to the Bland-Altman method (25). Second, we analyzed our data after excluding subjects who had a difference between their Ccr of the first urine collection and of the second urine collection of 2× the SD according to the Bland-Altman method. Therefore, we analyzed our data only of subjects for whom both Ccr were the same. Because both the first and the second analyses gave the same results as with the crude Ccr (in which we did not exclude subjects on these grounds), we show only the crude results.

Laboraroty Methods

Urinary albumin concentration was determined by nephelometry with a threshold of 2.3 mg/L and intra- and interassay coefficients of variation of ≤4.3% and ≤4.4%, respectively (Dade Behring Diagnostic, Marburg, Germany). Plasma glucose and serum and urinary creatinine were determined by Kodak Ektachem dry chemistry (Eastman Kodak, Rochester, NY). Urinary leukocyte and erythrocyte measurements were done by Nephur-test+leuco sticks (Boehringer Mannheim, Mannheim, Germany).

Data Handling and Definitions

In the present analysis, we started with the 8592 subjects from our actual study cohort. We excluded from this analysis 433 subjects because of erythrocyturia or leukocyturia, according to dipstick analysis (erythrocytes >50/ul or leukocytes >75/ul, or leukocytes = 75/ul and erythrocytes >5/ul) and 239 subjects because of diabetes, which was defined as fasting plasma glucose levels of ≥7.8 mmol/L or nonfasting plasma glucose levels of ≥11.1 mmol/L or the use of oral antidiabetic medication. Another 46 subjects were excluded because they were treated for proteinuria as a consequence of a renal disease. Finally, 146 subjects were excluded because of missing data on albuminuria, erythrocyturia, leukocyturia, plasma glucose levels, or renal disease. Altogether, 7728 subjects were eligible for this analysis.

Because it has been suggested that excess cardiovascular and renal risk may already be present at levels of UAE lower than the conventional definition of MA (30 to 300 mg/24 h) (3,26), we also investigated borderline elevated UAE (15 to 30 mg/24 h). This rendered us the following groups: the control group (0 to 15 mg/24 h; n = 5608), the high-normal albuminuria (HNA) group (15 to 30 mg/24 h; n = 1106), the MA group (30 to 300 mg/24 h; n = 932), and the macroalbuminuria group (>300 mg/24 h; n = 82). Obesity was defined as having a BMI of >30 kg/m2. Early and late renal functional abnormalities, such as elevated filtration and diminished filtration, were defined as a Ccr exceeding or below 2× the SD of the mean of the control group (9). The 2× SD borders of the mean were obtained by means of a linear regression analysis adjusted for age and gender.

Statistical Analyses

All calculations were performed with SPSS version 9.0 software (SPSS, Chicago, IL). Continuous data are reported as mean ± SD. In case of skewed distribution, the median with 95% confidence interval (CI) was used. All P values are two-tailed. A P value of <0.05 was considered statistically significant. Differences among the four UAE groups were assessed by χ2 analysis or ANOVA and tested for trend.

To investigate the risk of an elevated filtration or a diminished filtration, logistic regression analysis was used. Stepwise logistic regression analysis was used to test the independent relation among the four albuminuria groups and an elevated or a diminished filtration. The four albuminuria groups were entered into the regression analysis, and odds ratios were estimated after adjustment for possible confounding factors. We adjusted in this analysis for age, gender, BMI, systolic and diastolic BP, antihypertensive medication, plasma glucose, a positive family history for diabetes, and smoking. The calculated odds ratios and 95% CI are expressed as an approximation of RR.

Results

The characteristics of our study group according to the four different UAE groups are shown in Table 1. Age, BMI, minimal waist circumference, systolic and diastolic BP, and glucose showed a significant linear trend with each subsequent UAE level. Similarly, the frequencies of male gender, obesity, a positive family history, and the use of antihypertensive treatment also showed a linear trend with each subsequent UAE level. These differences remained statistically significant after adjusting for age and gender. There was no significant difference in smoking among the four different albuminuria groups. Concerning the renal characteristics, serum creatinine also followed a linear trend with each subsequent UAE level (P < 0.001). In contrast, the mean values for the 24-h Ccr followed a parabolic trend with each subsequent UAE level (P < 0.001). In other words, Ccr in the HNA group was elevated as compared with the control group, whereas it showed a decreasing trend in the MA and macroalbuminuria groups as compared with the HNA group.

View this table:
  • View inline
  • View popup
Table 1.

Population characteristics according to urinary albumin excretiona

To investigate whether this observed parabolic pattern could still be found after adjustment for the two most important confounders, age and gender, we analyzed Ccr in a general linear model. This additional analysis supported the finding of this parabolic pattern (Figure 1).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Creatinine clearance (Ccr) according to the four different albuminuria groups. The error bars represent the 95% confidence intervals. The numbers in the bars represent the age-and gender-adjusted mean of the Ccr (ml/min per 1.73m2).

Because the mean Ccr of a certain group is only the sum of subjects with a normal Ccr and subjects with an abnormal Ccr, this does offer optimal information about the relationship between albuminuria and an elevated or a diminished filtration as compared with normal subjects. Therefore, we also analyzed our data for subjects with an elevated or a diminished filtration. In a linear regression model, including age and gender, mean Ccr was calculated with the 2× SD borders. This is shown in Figure 2 for. Mean Ccr was 103 ± 19 ml/min per 1.73m2 in males 30 yr of age and 85 ± 19 ml/min per 1.73m2 in males 70 yr of age. In females 30 yr of age and 70 yr of age, the Ccr was 101 ± 18 ml/min per 1.73m2 and 76 ± 18 ml/min per 1.73m2, respectively. The 2× SD borders show the subjects with an elevated Ccr (n = 263) and with a diminished Ccr (n = 181), taking men and women together.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Ccr (ml/min per 1.73m2) as a function of age, with the two lines representing the upper and lower 2× SD borders of the mean according to the regression analysis. (A) Males. (B) Females. The subjects above the upper line represent subjects with an elevated filtration, and the subjects below the lower line represent subjects with a diminished filtration.

To investigate further the relation between an elevated or diminished Ccr and albuminuria, we analyzed our data in a logistic regression analysis (Table 2). We first analyzed our data adjusting only for age and gender. After also adjusting for all other possible confounders, such as BMI, plasma glucose, a positive family history for diabetes, BP, antihypertensive medication, and smoking, the results remained the same. An elevated filtration was associated with albuminuria, BMI, and plasma glucose, whereas it was inversely associated with the use of antihypertensive medication. Furthermore, a diminished filtration was associated with albuminuria, BMI, male gender, and antihypertensive medication, whereas it was inversely associated with plasma glucose. HNA and MA were associated with an increased RR for an elevated filtration (RR 1.8 [95% CI, 1.30 to 2.51], P < 0.001; and RR 1.7 [95% CI, 1.17 to 2.45], P < 0.01, respectively). Macroalbuminuria was also associated with an increased RR for an elevated filtration (RR 1.8 [95% CI, 0.64 to 5.23]), but this was not significant probably because of the small sample size (n = 82). Conversely, macroalbuminuria was associated with an increased RR for a diminished filtration (RR 4.3 [95% CI, 1.97 to 9.36], P < 0.001), whereas HNA was associated with a decreased RR for a diminished filtration (RR 0.3 [95% CI, 0.13 to 0.59], P < 0.001). In other words, HNA and MA are characterized by an elevated filtration, whereas macroalbuminuria is characterized by a diminished filtration. Moreover, a diminished filtration is not observed in association with HNA.

View this table:
  • View inline
  • View popup
Table 2.

Adjusted relative risk (RR) for elevated and diminished filtration according to the four different albuminuria groupsa

Discussion

This is the first, albeit cross-sectional, study that might shed some light on renal functional abnormalities in nondiabetic subjects in an early phase. Because diabetic subjects are usually followed for their diabetic disease, the course of their renal function is usually well known. Nondiabetic subjects come to medical attention only after the development of renal damage, which explains why little is known about early renal functional abnormalities in these subjects.

This study shows that the GFR in nondiabetic subjects might have a parabolic pattern that is associated with the different levels of UAE. In other words, the MA group has more subjects with an elevated filtration, whereas in the macroalbuminuria group more subjects with a diminished filtration can be found. It is interesting that the association between an elevated filtration and albuminuria was even more pronounced in subjects with a UAE thus far considered to be normal: 15 to 30 mg/24 h.

One could argue that those subjects with an elevated filtration or a diminished filtration have such a filtration only by coincidence, because of miscollection or because of the variability of the measurement. To test the validity of our data, we also analyzed our data after excluding subjects by the Bland-Altman method. The Bland-Altman method investigates the agreement between two measurements, which should measure the same. When there was more than a 2× SD difference of the mean between the two measurements, either Cockcroft versus Ccr, to correct for miscollections, or first versus second 24 h Ccr, to correct for variability, we excluded these subjects from the validity analysis. In other words, we analyzed our data only with subjects in whom the estimated Cockcroft clearancé was similar to the calculated 24-h Ccr and in whom the first versus the second calculated 24-h Ccr was similar. Because there was no difference in outcome, we did the final analysis without excluding any subjects on the basis of these grounds to avoid selection bias. We conducted a second validation by analyzing our data with Ccr not corrected for BSA. The uncorrected Ccr gave, if any, a somewhat higher RR. Because it is known that body mass influences renal function and because subjects with higher rates of albuminuria were also more obese, we thought it more appropriate to use the data of Ccr corrected for BSA.

We observed an increase in both Ccr and serum creatinine in the HNA group as compared with the control group (Table 1). This discrepancy could be due to a difference in body composition between the high-normal albuminuria group and the control group. Males were more prevalent in the HNA group, consistent with a greater muscle mass, which might explain the observed discrepancy.

The observed elevated or diminished filtration in the different albuminuria groups might be explained by other factors, such as age, gender, hypertension or antihypertensive treatment, hyperglycemia, and obesity. Indeed, hypertension (27,28), hyperglycemia (29), and obesity (30) have been described to be related to hyperfiltration, and it has been shown that antihypertensive treatment may also influence GFR (31). Because these factors were more prevalent in the groups with higher UAE, this may have introduced bias in the presented relation between albuminuria and Ccr. However, even after adjusting for systolic and diastolic BP, antihypertensive treatment, plasma glucose, and BMI, the association between albuminuria and an elevated or a diminished filtration persisted. It is therefore suggested that HNA and MA are independently associated with an elevated filtration, whereas macroalbuminuria is independently associated with a diminished filtration. The finding that HNA is associated with a lower risk for a diminished filtration emphasizes the finding that this group is mainly characterized by an elevated filtration.

The parabolic pattern in Ccr as shown in Figure 1 seems similar to the widely known parabolic or biphasic pattern in renal function as observed in diabetes. Although the renal hemodynamic abnormalities in diabetes are likely to be specific for the diabetic condition (32), it has been suggested that determinants of progressive renal function loss are similar for patients with established nondiabetic and diabetic renal disease (33).

One of the underlying mechanisms responsible for the observed early renal functional abnormalities in our nondiabetic subjects may be the consequence of insulin resistance. As mentioned before, subjects with an elevated UAE had higher BP, higher BMI, higher minimal waist circumference, and higher plasma glucose levels. These characteristics have been related to the insulin resistance syndrome (34). The insulin resistance syndrome may not only underlie NIDDM but can also be found in nondiabetic subjects (34). Within this context, MA has been argued to be part of the insulin resistance syndrome in diabetic (35,36,37,38) and nondiabetic subjects (19,39). The underlying mechanism for hyperfiltration or an impaired filtration might be related to hyperinsulinemia, associated with insulin resistance. In both animal (40) and human experimental research (41,42), hyperinsulinemia has been reported to influence GFR and has even been related to hyperfiltration. It has also been argued that insulin may also be responsible for an altered permeability of the glomerular membrane for albumin (43).

Because this study population after the selection procedure was enriched for albuminuria, one could argue that the population was also enriched for prediabetes. After correction in a multivariate model for characteristics of prediabetes, i.e., plasma glucose, BMI, systolic and diastolic BP, and a diabetic family history, the results remained the same. Therefore, there seems to be a robust effect of albuminuria on renal function, independent of prediabetes or insulin resistance. It is, however, difficult to unravel the responsibility of each unique part on renal function in a cross-sectional study. Nevertheless, these were nondiabetic subjects with early renal functional abnormalities in relation to albuminuria, which has not been shown before.

Apart from the observed elevated filtration in the HNA and microalbuminuric subjects, we observed an independent association with a diminished filtration in macroalbuminuric subjects. Taking together this parabolic pattern in Ccr, it is tempting to speculate that the group with “hyperfiltration” will eventually progress to renal functional impairment. However, we conducted only a cross-sectional study and cannot draw that conclusion without a longitudinal follow-up. When a longitudinal follow-up can confirm that subjects with an elevated filtration will indeed progress to renal functional impairment with a concomitant increase in UAE, an elevated UAE might be an important and early sign for progressive renal function loss in a nondiabetic population.

In conclusion, we found an association between UAE and renal function, i.e., an elevated Ccr in the stages of slightly elevated albuminuria and a lower Ccr in groups with higher UAE. Moreover, in these nondiabetic subjects, increased UAE is associated with a metabolic profile resembling the insulin resistance syndrome. Screening for albuminuria may identify nondiabetic subjects who are at risk for developing renal functional loss.

Acknowledgments

We thank research nurses Roelie Dijkstra-Oppenhuizen and Erika Konneman-van Zalk for their assistance at the outpatient clinic. Furthermore, we thank Winie G.A. de Jonge-Hovenkamp for her secretarial assistance, Dr. Enno van der Veur (general practitioners laboratory, Groningen) and Jacko J. Duker (Nephrology Laboratory, University Hospital, Groningen) for their laboratory assistance, and Drs. Frank P.G. Lambert and Robert J. Bieringa (Trial Coördination Center, Groningen) for the data handling. We also thank the Dutch Kidney Foundation for supporting this research project (Grant No. E033).

  • © 2000 American Society of Nephrology

References

  1. ↵
    Viberti GC, Hill RD, Jarret RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430 -1432, 1982
    OpenUrlCrossRefPubMed
  2. ↵
    Mogensen CE, Christensen CK, Vittinghus E: The stages in diabetic renal disease: With emphasis on the stage of incipient diabetic nephropathy. Diabetes 32[Suppl 2]:64 -78, 1983
  3. ↵
    Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356-360,1984
    OpenUrlCrossRefPubMed
  4. ↵
    Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B, Sambataro M, Abaterusso C, Baggio B, Crepaldi G, Nosadini R: Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 39:1569 -1576, 1996
    OpenUrlCrossRefPubMed
  5. ↵
    Mogensen CE, Hansen KW, Nielsen S, Maudersen M, Rehling M, Schmitz A: Monitoring diabetic nephropathy: Glomerular filtration rate and abnormal albuminuria in diabetic renal disease—Reproducibility, progression, and efficacy of antihypertensive intervention. Am J Kidney Dis 22: 174-187,1993
    OpenUrlPubMed
  6. ↵
    Parving HH, Kastrup H, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS: Impaired autoregulation of glomerular filtration rate in type I (insulin-dependent) diabetic patients with nephropathy. Diabetologia 27:547 -555, 1984
    OpenUrlCrossRefPubMed
  7. ↵
    Mogensen CE: Early glomerular hyperfiltration in insulin-dependent diabetes and late nephropathy. Scan J Clin Lab Invest46 : 201-206,1986
    OpenUrlCrossRefPubMed
  8. ↵
    Rudberg S, Persson B, Dahlquist G: Increased glomerular filtration rate as a predictor of diabetic nephropathy: An 8-year prospective study. Kidney Int 41:822 -828, 1992
    OpenUrlCrossRefPubMed
  9. ↵
    Vora JP, Dolben J, Dean JD, Thomas D, Williams JD, Owens DR, Peters JR: Renal haemodynamics in newly presenting non-insulin-dependent diabetes mellitus. Kidney Int 41:829 -835, 1992
    OpenUrlCrossRefPubMed
  10. ↵
    Schmitz A, Hansen HH, Christensen T: Kidney function in newly diagnosed type 2 diabetic patients before and during treatment. Diabetologia 32:434 -439, 1989
    OpenUrlCrossRefPubMed
  11. ↵
    Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72:375 -380, 1982
    OpenUrlCrossRefPubMed
  12. ↵
    Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85 -F93, 1981
    OpenUrlPubMed
  13. ↵
    Hostetter TH, Rennke HG, Brenner BM: Compensatory renal hemodynamic injury: A final common pathway of residual nephron destruction. Am J Kidney Dis 1:310 -314, 1982
    OpenUrlPubMed
  14. ↵
    Olson JL, Hostetter TH, Rennke HG, Brenner BM, Venkatachalam MA: Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int22 : 112-126,1982
    OpenUrlCrossRefPubMed
  15. ↵
    Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384-394,1990
    OpenUrlCrossRefPubMed
  16. ↵
    Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int23 : 647-655,1983
    OpenUrlCrossRefPubMed
  17. ↵
    Bigazzi R, Bianchi S, Campese V, Baldari G: Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron61 : 94-97,1992
    OpenUrlCrossRefPubMed
  18. ↵
    Haffner SM, Stern MP, Gruber K, Hazuda HP, Mitchell BD, Patterson JK: Microalbuminuria: Potential marker for increased cardiovascular risk factors in non-diabetic subjects? Arteriosclerosis10 : 727-731,1990
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Haffner SM, Gonzales C, Valdez RA, Mykkänen L, Hazuda HP, Michell BD, Monterrosa A, Stern MP: Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia36 : 1002-1006,1993
    OpenUrlCrossRefPubMed
  20. ↵
    Lokkegaard N, Haupter I, Kristensen T: Microalbuminuria in obesity. Scand J Urol Nephrol 26:275 -278, 1992
    OpenUrlPubMed
  21. ↵
    Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Prognostic value of urinary albumin excretion rate and other risk factors in elderly diabetic patients and non-diabetic control subjects surviving the first 5 years after assessment. Diabetologia36 : 1030-1036,1993
    OpenUrlCrossRefPubMed
  22. ↵
    Karter AJ, Mayer-Davis EJ, Selby JV, D'Agostino RB, Haffner SM, Sholinsky P, Bergman R, Saad MF, Hamman RF: Insulin sensitivity and abdominal obesity in African-American, Hispanic and non-Hispanic white men and women: The Insulin Resistance and Atherosclerosis Study. Diabetes 45:1547 -1555, 1996
    OpenUrlAbstract/FREE Full Text
  23. ↵
    DuBois DF, DuBois EF: A formula to estimate the approximate surface area if height and weight are known. Arch Intern Med17 : 863-871,1916
    OpenUrl
  24. ↵
    Cockcroft DW, Gault HM: Prediction of creatinine clearance from serum creatinine. Nephron 16:31 -41, 1976
    OpenUrlCrossRefPubMed
  25. ↵
    Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet1 : 307-310,1986
    OpenUrlCrossRefPubMed
  26. ↵
    Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ: Microalbuminuria predicts mortality in non-insulin dependent diabetes. Diabet Med 1:17 -19, 1984
    OpenUrlCrossRefPubMed
  27. ↵
    Cottone S, Cerasola G: Microalbuminuria fractional clearance and early renal permselectivity changes in essential hypertension. Am J Nephrol 12:326 -329, 1992
    OpenUrlPubMed
  28. ↵
    Schmieder RE, Veelken R, Schobel H, Dominiak P, Mann JFE, Luft FC: Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension. J Am Soc Nephrol8 : 893-900,1997
    OpenUrlAbstract
  29. ↵
    Wiseman MJ, Mangili R, Alberetto M, Keen H, Viberti G: Glomerular response mechanisms to glycemic changes in insulin-dependent diabetics. Kidney Int 31:1012 -1018, 1987
    OpenUrlPubMed
  30. ↵
    Ribstein J, du Cailar G, Mimran A: Combined effects of overweight and hypertension. Hypertension26 : 610-615,1995
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Schmieder RE: Nephroprotection by antihypertensive agents. J Cardiovasc Pharmacol 24:S55 -S64, 1994
  32. ↵
    de Jong PE, Heeg JE, Apperloo AJ, de Zeeuw D: The antiproteinuric effects of blood pressure lowering agents: Differences between non-diabetics and diabetics. J Cardiovasc Pharmacol19 : S28-S32,1992
  33. ↵
    Navis GJ, de Jong PE, de Zeeuw D: A comparison of progression in diabetic and non-diabetic renal disease: Similarity of progression promoters. In: The Kidney and Hypertension in Diabetes Mellitus, 4th Ed., edited by Mogensen CE, Boston, Kluwer Academic Publishers,1998 , pp 585-595
  34. ↵
    Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595 -1607, 1988
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Groop LC, Ekstrand AV, Forsblom CM, Widen E, Groop PH, Teppo AM, Eriksson JG: Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:642 -647, 1993
    OpenUrlCrossRefPubMed
  36. ↵
    Nosadini R, Cipollina MR, Solini A, Sambataro M, Morocutti A, Doria A, Fioretto P, Brocco E, Muollo B, Frigato F: Close relationship between microalbuminuria and insulin resistance in essential hypertension and non-insulin dependent diabetes mellitus. J Am Soc Nephrol 3:S56 -S63, 1992
    OpenUrlAbstract
  37. ↵
    Zambon S, Manzato E, Solini A, Sambataro M, Brocco E, Sartore G, Crepaldi G, Nosadini R: Lipoprotein abnormalities in non-insulin-dependent diabetic patients with impaired extrahepatic insulin sensitivity, hypertension, and microalbuminuria. Arterioscler Thromb 14:911 -916, 1994
    OpenUrlAbstract/FREE Full Text
  38. ↵
    Niskanen L, Laakso M: Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. Metabolism 42:1541 -1545, 1993
    OpenUrlCrossRefPubMed
  39. ↵
    Forsblom CM, Eriksson JG, Ekstrand AV, Teppo AM, Taskinen MR, Groop LC: Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia 38:363 -369, 1995
    OpenUrlCrossRefPubMed
  40. ↵
    Park SK, Kang SK: Renal function and hemodynamic study in obese Zucker rats. Korean J Intern Med10 : 48-53,1995
    OpenUrlCrossRefPubMed
  41. ↵
    Kubo M, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Hirakata H, Fujishima M: Effect of hyperinsulinemia on renal function in a general Japanese population: The Hisayama Study. Kidney Int55 : 2450-2456,1999
    OpenUrlCrossRefPubMed
  42. ↵
    Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Ritz E: Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int53 : 1343-1347,1998
    OpenUrlCrossRefPubMed
  43. ↵
    Nestler JE, Barlascini CO, Tetrault GA: Increased transcapillary escape rate of albumin in non-diabetic men in response to hyperinsulinemia. Diabetes 39:1212 -1217, 1990
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 11 (10)
Journal of the American Society of Nephrology
Vol. 11, Issue 10
1 Oct 2000
  • Table of Contents
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Urinary Albumin Excretion Is Associated with Renal Functional Abnormalities in a Nondiabetic Population
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Urinary Albumin Excretion Is Associated with Renal Functional Abnormalities in a Nondiabetic Population
SARA-JOAN PINTO-SIETSMA, WILBERT M.T. JANSSEN, HANS L. HILLEGE, GERJAN NAVIS, DICK DE ZEEUW, PAUL E. DE JONG
JASN Oct 2000, 11 (10) 1882-1888;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Urinary Albumin Excretion Is Associated with Renal Functional Abnormalities in a Nondiabetic Population
SARA-JOAN PINTO-SIETSMA, WILBERT M.T. JANSSEN, HANS L. HILLEGE, GERJAN NAVIS, DICK DE ZEEUW, PAUL E. DE JONG
JASN Oct 2000, 11 (10) 1882-1888;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • A Randomized, Controlled Trial of Steroids and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy
  • Lower Progression Rate of End-Stage Renal Disease in Patients with Peripheral Arterial Disease Using Statins or Angiotensin-Converting Enzyme Inhibitors
  • IgACE: A Placebo-Controlled, Randomized Trial of Angiotensin-Converting Enzyme Inhibitors in Children and Young People with IgA Nephropathy and Moderate Proteinuria
Show more Clinical Nephrology

Cited By...

  • Association of Increasing GFR with Change in Albuminuria in the General Population
  • GlycA, a novel proinflammatory glycoprotein biomarker, and high-sensitivity C-reactive protein are inversely associated with sodium intake after controlling for adiposity: the Prevention of Renal and Vascular End-Stage Disease study
  • Obesity and Cardiovascular Disease
  • Renal Mechanisms of Association between Fibroblast Growth Factor 1 and Blood Pressure
  • Plasma 1,25-Dihydroxyvitamin D and the Risk of Developing Hypertension: The Prevention of Renal and Vascular End-Stage Disease Study
  • Apolipoprotein B Attenuates Albuminuria-Associated Cardiovascular Disease in Prevention of Renal and Vascular Endstage Disease (PREVEND) Participants
  • GFR Estimating Equations: Getting Closer to the Truth?
  • Glomerular and Tubular Damage Markers in Individuals with Progressive Albuminuria
  • Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes
  • Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population
  • Comparative Effects of Low-Carbohydrate High-Protein Versus Low-Fat Diets on the Kidney
  • Association Between Sodium Intake and Change in Uric Acid, Urine Albumin Excretion, and the Risk of Developing Hypertension
  • Comparison of Midregional Pro-A-Type Natriuretic Peptide and the N-Terminal Pro-B-Type Natriuretic Peptide for Predicting Mortality and Cardiovascular Events
  • Overexpression of VEGF165b in Podocytes Reduces Glomerular Permeability
  • Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease
  • Early Renal Abnormalities in Autosomal Dominant Polycystic Kidney Disease
  • Intelligence is negatively associated with the number of functional somatic symptoms
  • High Protein Intake Associates with Cardiovascular Events but not with Loss of Renal Function
  • Screening for Albuminuria Identifies Individuals at Increased Renal Risk
  • First Morning Voids Are More Reliable Than Spot Urine Samples to Assess Microalbuminuria
  • Extended Prognostic Value of Urinary Albumin Excretion for Cardiovascular Events
  • Microalbuminuria in Type 2 Diabetes and Hypertension: A marker, treatment target, or innocent bystander?
  • Plasma Free Metanephrine Measurement Using Automated Online Solid-Phase Extraction HPLC Tandem Mass Spectrometry
  • What Predicts Progression and Regression of Urinary Albumin Excretion in the Nondiabetic Population?
  • Prolonged Frozen Storage of Urine Reduces the Value of Albuminuria for Mortality Prediction
  • Macroalbuminuria Is a Better Risk Marker than Low Estimated GFR to Identify Individuals at Risk for Accelerated GFR Loss in Population Screening
  • Screening, Monitoring, and Treatment of Albuminuria: Public Health Perspectives
  • Early Detection of Progressive Chronic Kidney Disease: Is It Feasible?
  • Endothelial Dysfunction Contributes to Renal Function-Associated Cardiovascular Mortality in a Population with Mild Renal Insufficiency: The Hoorn Study
  • Vascular Function and Mild Renal Impairment in Stable Coronary Artery Disease
  • Urinary Albumin Excretion as a Predictor of the Development of Hypertension in the General Population
  • Falsely Low Urinary Albumin Concentrations after Prolonged Frozen Storage of Urine Samples
  • Urinary Albumin Excretion and Its Relation With C-Reactive Protein and the Metabolic Syndrome in the Prediction of Type 2 Diabetes
  • Birth Weight and Creatinine Clearance in Young Adult Twins: Influence of Genetic, Prenatal, and Maternal Factors
  • Microalbuminuria in Cats
  • Drawbacks of the Use of Indirect Estimates of Renal Function to Evaluate the Effect of Risk Factors on Renal Function
  • C-Reactive Protein Modifies the Relationship Between Blood Pressure and Microalbuminuria
  • Activation of the Signal Transducer and Activator of Transcription Signaling Pathway in Renal Proximal Tubular Cells by Albumin
  • Risk Factors for Chronic Kidney Disease: A Prospective Study of 23,534 Men and Women in Washington County, Maryland
  • Role of the Endothelin-1 Gene Locus for Renal Impairment in the General Nondiabetic Population
  • Induction of Glia Maturation Factor-{beta} in Proximal Tubular Cells Leads to Vulnerability to Oxidative Injury through the p38 Pathway and Changes in Antioxidant Enzyme Activities
  • Cardiovascular Risk Factors Are Differently Associated with Urinary Albumin Excretion in Men and Women
  • Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population
  • Risk Factors for Proteinuria in a Large, Multiracial, Southeast Asian Population
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire